ADC Therapeutics S.A. (ADCT)
NYSE · Healthcare
ADC Therapeutics S.A. Revenue 2022–2025
ADC Therapeutics S.A. annual/quarterly revenue history and growth rate from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- ADC Therapeutics S.A. revenue for the quarter ending March 31, 2026 was 20.0 M, a 15.11% increase year-over-year.
- ADC Therapeutics S.A. revenue for the twelve months ending March 31, 2026 was 71.3 M, a 6.12% increase year-over-year.
- ADC Therapeutics S.A. annual revenue for 2025 was 81.4 M, a 14.85% increase from 2024.
- ADC Therapeutics S.A. annual revenue for 2024 was 70.8 M, a 2.57% increase from 2023.
- ADC Therapeutics S.A. annual revenue for 2023 was 69.1 M, a 7.81% decrease from 2022.
- ADC Therapeutics S.A. annual revenue for 2022 was 74.9 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
ADC Therapeutics S.A. Earnings — FAQ
ADC Therapeutics S.A. (ADCT) earnings over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ADCT's earnings history?
The chart and table above show ADC Therapeutics S.A.'s earnings by year and by quarter, including the growth rate.